$PFE News Stock market live blog: SP 500 record,
Post# of 145223
Posted On: 11/21/2013 6:22:53 PM
$PFE News
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
How to buy bitcoin 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
Pfizer Gets FDA Nod for Xalkori Lung Cancer Drug and 2 Other Dow Movers to Watch 1:53 p.m. Today - Wall St. Cheat Sheet
Data on Amgen's Pipeline Candidates - Analyst Blog 11:50 a.m. Today - Zacks.com
Stock Market News for November 21, 2013 - Market News 10:06 a.m. Today - Zacks.com
Athersys Narrows Loss, Shares Rise - Analyst Blog 9:00 a.m. Today - Zacks.com
Daiichi Sankyo's Factor Xa Inhibitor Edoxaban Clears Phase III Hurdle - A Major Threat To Xarelto And Eliquis 8:35 a.m. Today - Seeking Alpha
Roche's Kadcyla Approved in the EU - Analyst Blog 5:35 p.m. Nov. 20, 2013 - Zacks.com
Will Recent News Hurt Johnson & Johnson? 5:08 p.m. Nov. 20, 2013 - Wall St. Cheat Sheet
Amazon.com Cloud Push Seen Creating 'Losers' In IT 4:21 p.m. Nov. 20, 2013 - Investors Business Daily
Early Warning Signs of a Dividend Cut 10:39 a.m. Nov. 20, 2013 - GuruFocus.com
Daiichi Sankyo's edoxaban holds its own in clinical testing 10:26 a.m. Nov. 20, 2013 - Seeking Alpha
EU Clears Roche Cancer Drug 5:44 a.m. Nov. 20, 2013 - WSJ.com
More Boards Recruit Ex-CEOs 9:47 p.m. Nov. 19, 2013 - WSJ.com
QIAGEN, Eli Lilly Expand Partnership - Analyst Blog 6:58 p.m. Nov. 19, 2013 - Zacks.com
New Tricks in Animal Health 6:05 p.m. Nov. 19, 2013 - WSJ.com
Nokia Shareholders Nod to Microsoft Deal and 2 Other Hot Stocks to Watch 12:38 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Bullying: Deal With It 12:16 p.m. Nov. 19, 2013 - FOXBusiness
The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years 11:03 a.m. Nov. 19, 2013 - 247WallSt.com
Salesforce's Q3 Loss Widens - Analyst Blog 9:30 a.m. Nov. 19, 2013 - Zacks.com
Pfizer Inc's Buy Recommendation Affirmed 9:00 a.m. Nov. 19, 2013 - TheStreet.com
4 ETFs to Turbocharge Your Returns 3:22 a.m. Nov. 19, 2013 - InvestorPlace.com
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Today - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Today - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Today - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Today - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
How to buy bitcoin 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Apple angst, India rate hike: The next 24 hours in markets 6:17 p.m. Oct. 28, 2013 - blogs.marketwatch.com
Pfizer Gets FDA Nod for Xalkori Lung Cancer Drug and 2 Other Dow Movers to Watch 1:53 p.m. Today - Wall St. Cheat Sheet
Data on Amgen's Pipeline Candidates - Analyst Blog 11:50 a.m. Today - Zacks.com
Stock Market News for November 21, 2013 - Market News 10:06 a.m. Today - Zacks.com
Athersys Narrows Loss, Shares Rise - Analyst Blog 9:00 a.m. Today - Zacks.com
Daiichi Sankyo's Factor Xa Inhibitor Edoxaban Clears Phase III Hurdle - A Major Threat To Xarelto And Eliquis 8:35 a.m. Today - Seeking Alpha
Roche's Kadcyla Approved in the EU - Analyst Blog 5:35 p.m. Nov. 20, 2013 - Zacks.com
Will Recent News Hurt Johnson & Johnson? 5:08 p.m. Nov. 20, 2013 - Wall St. Cheat Sheet
Amazon.com Cloud Push Seen Creating 'Losers' In IT 4:21 p.m. Nov. 20, 2013 - Investors Business Daily
Early Warning Signs of a Dividend Cut 10:39 a.m. Nov. 20, 2013 - GuruFocus.com
Daiichi Sankyo's edoxaban holds its own in clinical testing 10:26 a.m. Nov. 20, 2013 - Seeking Alpha
EU Clears Roche Cancer Drug 5:44 a.m. Nov. 20, 2013 - WSJ.com
More Boards Recruit Ex-CEOs 9:47 p.m. Nov. 19, 2013 - WSJ.com
QIAGEN, Eli Lilly Expand Partnership - Analyst Blog 6:58 p.m. Nov. 19, 2013 - Zacks.com
New Tricks in Animal Health 6:05 p.m. Nov. 19, 2013 - WSJ.com
Nokia Shareholders Nod to Microsoft Deal and 2 Other Hot Stocks to Watch 12:38 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Bullying: Deal With It 12:16 p.m. Nov. 19, 2013 - FOXBusiness
The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years 11:03 a.m. Nov. 19, 2013 - 247WallSt.com
Salesforce's Q3 Loss Widens - Analyst Blog 9:30 a.m. Nov. 19, 2013 - Zacks.com
Pfizer Inc's Buy Recommendation Affirmed 9:00 a.m. Nov. 19, 2013 - TheStreet.com
4 ETFs to Turbocharge Your Returns 3:22 a.m. Nov. 19, 2013 - InvestorPlace.com
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Today - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Today - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Today - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Today - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
2013 mHealth Summit Launches First Pharma and Life Sciences Roundtable 2:31 p.m. Nov. 6, 2013 - PR Newswire
Former U.S. President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern 12:32 p.m. Nov. 5, 2013 - BusinessWire
Pfizer Receives FDA Approval for a Prior Approval Supplement for EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII 5:14 p.m. Nov. 4, 2013 - BusinessWire
Therapeutic Area Partnerships Feature Pharma Leaders Who Unveil How to Pick Drug Targets, Partners, and Deal Models Most Likely to Succeed 9:00 a.m. Nov. 4, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
(0)
(0)